Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Long-Term Debt Repayments (2024 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Long-Term Debt Repayments for 3 consecutive years, with -$40.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Long-Term Debt Repayments changed N/A year-over-year to -$40.8 million, compared with a TTM value of $40.8 million through Jun 2025, down 83.44%, and an annual FY2024 reading of $246.1 million, changed N/A over the prior year.
  • Long-Term Debt Repayments was -$40.8 million for Q3 2025 at Tandem Diabetes Care, down from $40.8 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $246.1 million in Q1 2024 and bottomed at -$40.8 million in Q3 2025.